🏛️ Verified NIH Record • Updated 2026-05-27

AIDANET Pediatrics (NCT07020936)

🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Mark D. DeBoer, MD, MSc., MCR

🩺 Plain-English Summary (8th-Grade Level)

AIDANET algorithm with smart-phone based control system (study smart phone), specifically modified Tandem insulin system (study insulin pump), and Dexcom G6 CGM (study CGM).

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (15 items) and avoid the listed exclusions (17 items).

Location: University of California San Francisco — San Francisco, California

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Usually NOT eligible if any of the following apply:

  • Exclusion Criteria:
  • Plans to start a new non-insulin glucose-lowering agent (e.g., GLP-1 receptor agonists, Symlin, DPP-4 inhibitors, sulfonylureas). Participants may be on a stable dose of such an agent for at least the past month.
  • Current use of an SGLT-2 or SGLT-1/2 inhibitor due to risk of euglycemic Diabetic ketoacidosis (DKA).
  • Hemophilia or any other bleeding disorder.
  • History of severe hypoglycemic events with seizure or loss of consciousness in the last 6 months.
  • History of diabetic ketoacidosis (DKA) event in the last 6 months.
  • History of chronic renal disease (Stage 4 or unstable Stage 3b per investigator judgment) or currently on peritoneal or hemodialysis.
  • History of adrenal insufficiency.
  • Currently being treated for a seizure disorder.
  • Hypothyroidism or hyperthyroidism that is not adequately treated.
  • Coronary artery disease or other heart condition that would prevent participation in moderate intensity exercise.
  • Use of oral or injectable steroids at the time of enrollment or within the last 4 weeks.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (3 Sites)

  • University of California San Francisco — San Francisco, California
  • Barbara Davis Center, University of Colorado — Aurora, Colorado
  • University of Virginia Center for Diabetes Technology — Charlottesville, Virginia

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
🏛️ View Official NIH Record ↗